Indications for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)-Seagull Pharmacy

new

Indications for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)

514

Article source: Seagull Pharmacy

Nov 06, 2025

Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is an innovative oral combination anti-diabetic formulation that integrates the dual advantages of a dipeptidyl peptidase-4 (DPP-4) inhibitor and a biguanide agent.

Indications for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)

Primary Indication

Adjunctive treatment for type 2 diabetes in adults: Serving as an effective supplement to dietary control and exercise therapy, it is specifically indicated to improve blood glucose control in adult patients with type 2 diabetes.

Special Precautions

Contraindicated Populations: It must not be used for the treatment of patients with type 1 diabetes.

Risk of Pancreatitis: No systematic studies have been conducted in patients with a history of pancreatitis, so it cannot be determined whether the use of this drug in such patients will increase the risk of developing pancreatitis. A rigorous assessment of medication safety is necessary.

Dosage Strengths and Physical Characteristics of Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)

Sitagliptin 100 mg / Metformin Hydrochloride 1000 mg Extended-Release Tablets

Physical Appearance: Blue, biconvex, oval-shaped film-coated tablets.

Identification Marking: Imprinted with the code "81" on one side as an anti-counterfeiting mark.

Sitagliptin 50 mg / Metformin Hydrochloride 500 mg Extended-Release Tablets

Physical Appearance: Light blue, biconvex, oval-shaped film-coated tablets.

Identification Marking: Imprinted with the code "78" on one side.

Sitagliptin 50 mg / Metformin Hydrochloride 1000 mg Extended-Release Tablets

Physical Appearance: Light green, biconvex, oval-shaped film-coated tablets.

Identification Marking: Imprinted with the code "80" on one side.

Storage Instructions for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)

Temperature Control Standards

Ideal Storage Temperature: 20°C to 25°C (68°F to 77°F).

Allowable Temperature Fluctuation Range: 15°C to 30°C (59°F to 86°F).

Storage Environment Requirements: Store in a dry area with the container tightly sealed.

Key Points for Packaging Management

Maintenance of Original Packaging: The original packaging must be retained, and the bottle cap must be kept tightly closed.

Child Safety Protection: Store the product in an area that is out of the reach of children.

Usage and Handling Specifications: Reseal the container immediately after each dose is taken.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.

Recommended Articles

What Are the Side Effects of Tivozanib (Fotivda)?

Tivozanib (Fotivda) is a targeted therapy drug for recurrent or refractory advanced renal cell carcinoma, offering new hope to patients who have undergone multiple lines of systemic treatment. However...

Precautions for Administration of Tivozanib (Fotivda)

Tivozanib (Fotivda) is a kinase inhibitor. By targeting multiple tyrosine kinase targets such as vascular endothelial growth factor receptor (VEGFR), it inhibits tumor angiogenesis and is used for the...

How to Use Tivozanib (Fotivda)

Tivozanib (Fotivda) is a kinase inhibitor that was first approved in the United States in 2021. This medication is specifically indicated for the treatment of adult patients with advanced renal cell c...

Indications for Tivozanib Capsules (Fotivda)

Tivozanib Capsules (Fotivda) is a kinase inhibitor that was first approved in the United States in 2021. As an important drug for the treatment of advanced renal cell carcinoma, it blocks tumor angiog...

How to Use Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)

Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is a fixed-dose combination antihyperglycemic medication. It contains sitagliptin (a dipeptidyl peptidase-4 inhibitor) and met...

What Are the Side Effects of Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)?

Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is a fixed-dose combination preparation for the treatment of type 2 diabetes. It provides effective blood glucose control for ...

How to Purchase Enstilar

Enstilar is a prescription medication and must be obtained in strict compliance with medical regulatory procedures. It contains calcipotriene (a vitamin D analog) and betamethasone dipropionate (a cor...

Indications for Enstilar

Enstilar is an innovative topical fixed-dose combination preparation that integrates the dual effects of a vitamin D analog and a corticosteroid, specifically designed for the treatment of plaque psor...

Contraindications and adverse reactions of Anagrelide

Although anagrelide has no absolute contraindications, special populations and concomitant medications require extra caution, and adverse reactions involve multiple systems.I. Contraindications and Si...

Special population medication for Anagrelide

The use of anagrelide in special populations requires individualized assessment. The following explains key points by population category.I. Pregnant and Breastfeeding Women1. Use During PregnancyAvai...

Precautions for Healthy Diet in Anagrelide Patients

Anagrelide is used to lower platelets, and diet needs to cooperate with the drug's efficacy, reduce bleeding and cardiovascular risks. The following provides recommendations from three aspects.I. ...

Contraindications and adverse reactions of itraconazole

Although eltrombopag has no absolute contraindications, it has clear warnings and potential serious adverse reactions. Understanding these risks is a prerequisite for safe medication use.I. Contraindi...

Special population medication of eltrombopag

The use of eltrombopag in special populations requires individualized adjustment. This article reviews key medication points around factors such as hepatic and renal function, age, and ethnicity.I. Do...

Precautions for healthy diet of patients with eltrombopag

When taking eltrombopag, diet directly affects drug absorption and efficacy. Mastering the correct dietary principles is an important part of ensuring safe and effective treatment.I. Timing of Medicat...

Contraindications and adverse reactions of Epclusa

Epclusa is generally well tolerated, but contraindications and adverse reactions require special attention when combined with ribavirin. The following explains from three aspects.I. Contraindications1...

Special population use of Epclusa

Epclusa requires no dosage adjustment in most special populations, but some populations require careful evaluation. The following explains three situations separately.I. Populations with Abnormal Live...

Core Drugs